Treatment Commences in Second Patient Cohort in Cynata’s World First Clinical Trial Biotech Investing
MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis Biotech Investing
UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option Biotech Investing
Sorrento Therapeutics CAR-T Manufacturing Capacity Expanded With Opening of East Coast GMP Site in Addition to Primary West Coast Facility Biotech Investing
Exalenz Bioscience Announces Positive Clinical Trial Results For the Diagnosis of Clinically Significant Portal Hypertension Biotech Investing
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares Biotech Investing
FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna Biotech Investing
